HOME >> BIOLOGY >> NEWS
$1.7 million for Rutgers anti-HIV drug research

NEW BRUNSWICK/PISCATAWAY, N.J. Monday, June 5, marked the 25-year anniversary of the discovery of AIDS, and Rutgers researchers have just received new funds to support their pursuit of new ways to combat the virus. Patrick J. Sinko, Parke-Davis Professor of Pharmaceutics and Drug Delivery at Rutgers' Ernest Mario School of Pharmacy, has received a highly selective National Institutes of Health (NIH) MERIT award for more than $1.7 million.

The funding will support up to a 10-year extension of Sinko's continuing research into nanotechnology-based, targeted drug delivery for the treatment of human immunodeficiency virus (HIV), the virus that causes AIDS. Sinko, chair of the department of pharmaceutics at Rutgers, The State University of New Jersey, and his team are working to develop drug delivery systems to treat HIV-infected cells, and to assist the delivery of potent anti-HIV drugs to areas of the body that are typically difficult to access, such as the brain.

A limited number of the NIH MERIT (Method to Extend Research in Time) awards are made to investigators who have demonstrated superior competence and outstanding productivity in their research and are likely to do so in the future. Fewer than 5 percent of NIH grantees receive these awards.

Sinko has just completed four years of research supported by a $1.1 million grant from the National Institute of Allergy and Infectious Disease of the NIH. The $1.7 million MERIT award will now extend support of his research for five years. The grant is also potentially renewable for another five years with additional funding.

"Receiving a MERIT award from the National Institutes of Health represents an extraordinary level of scientific recognition and a confirmation of the importance of this innovative research," said John Colaizzi, dean of the Ernest Mario School of Pharmacy.

Sinko's delivery systems use nanocarriers miniscule biological "capsules" whose size is measured in billiont
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
6-Jun-2006


Page: 1 2

Related biology news :

1. US Department of Defense awards $1.6 million for implantable biochip research
2. Nottingham biosciences million pound injection
3. $9 million EPSCoR grant to foster integrated research
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. $125 million bioenergy initiative powered by Midwest ag industry, MSU research
6. UC Davis is partner in new $125 million federal bioenergy research center
7. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
8. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
9. New $1.16 million study investigates how dietary iron is used by cells
10. 5.9 million award gives UK aging research a new lease on life
11. NIH awards nearly $21 million to fund cutting-edge research equipment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... ... Greenberg Traurig, LLP attorneys Stephen Baird , - ... Minnesota, Sept. 9-10, at the Hyatt Regency, Minneapolis. Greenberg Traurig is a founding sponsor ... Group have been featured speakers at every DeviceTalks conference since 2011. , On ...
(Date:9/8/2019)... ... September 06, 2019 , ... ... of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announces its ... paired cell and media system designed for product development. RoosterBio continues to ...
(Date:8/31/2019)... ... August 30, 2019 , ... Today marks ... Natalist empowers consumers in the preconception period with doctor-approved products and resources, including ... month that are trying to get pregnant. , Natalist is built on the ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... KITCHENER, Ontario (PRWEB) , ... October 02, 2019 ... ... protein sequencing using mass spectrometry, is pleased to announce that it has moved ... mass spectrometers among other analytical instruments, the new facility demonstrates the company's continuous ...
(Date:9/24/2019)... , ... September 24, 2019 ... ... presenting their latest research in the area of high-level X-ray methods using ... Pamela Smith, COO of Improved Pharma, will present “Synchrotron X-Ray Diffraction and ...
(Date:9/24/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... clinical trial sites and physician investigators. The clinical trial sites are now ... Clinical trial sites are currently located in San Diego and Los Angeles California, ...
(Date:9/22/2019)... ... 2019 , ... ZRT Laboratory is pleased to ... . BDNF plays a vital role in protecting existing neurons in the central ... in the brain involved in learning, memory, and higher thinking. Low serum levels ...
Breaking Biology Technology:
Cached News: